BLOOD BILIRUBIN ABNORMAL side effect
What is BLOOD BILIRUBIN ABNORMAL ?Drugs associated with BLOOD BILIRUBIN ABNORMAL
ALIMTA ARGATROBAN BEVACIZUMAB CHANTIX ENBREL ETOPOSIDE INTRALIPID LIPITOR MIRTAZAPINE PEDIMUNE TRACLEER WINRHOBLOOD BILIRUBIN ABNORMAL : Pedimune Side Effects Report #5679525-7
Consumer or non-health professional from reported PEDIMUNE problem on Mar 12, 2008. Female patient was diagnosed with hiv infection and was treated with PEDIMUNE. After drug was administered, patient experienced the following problems/side effects: blood bilirubin abnormal, pneumonia, . PEDIMUNE dosage: unknown. Patient died.
BLOOD BILIRUBIN ABNORMAL : Alimta Side Effects Report #5631961-0
ALIMTA problem was reported by a Physician from UNITED STATES on Feb 11, 2008. Male patient, weighting 273.0 lb, was diagnosed with adenocarcinoma pancreas, constipation and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: blood albumin abnormal, blood bilirubin abnormal, blood glucose abnormal, pulmonary artery thrombosis, supraventricular tachycardia, . ALIMTA dosage: 300 MG/M2, OTHER. During the same period patient was treated with LEVAQUIN, COUMADIN, MIRALAX, LOVENOX, LOPRESSOR, SENOKOT. Patient was hospitalized. Patient recovered.
BLOOD BILIRUBIN ABNORMAL : Alimta Side Effects Report #5640848-9
Physician from UNITED STATES reported ALIMTA problem on Feb 19, 2008. Male patient, weighting 273.0 lb, was diagnosed with adenocarcinoma pancreas, constipation and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: blood albumin abnormal, blood bilirubin abnormal, blood glucose abnormal, pulmonary artery thrombosis, supraventricular tachycardia, . ALIMTA dosage: 300 MG/M2, OTHER. During the same period patient was treated with LEVAQUIN, COUMADIN, MIRALAX, LOVENOX, LOPRESSOR, SENOKOT. Patient was hospitalized. Patient recovered.
BLOOD BILIRUBIN ABNORMAL : Lipitor Side Effects Report #5512012-5
LIPITOR problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 01, 2007. Male patient was treated with LIPITOR. After drug was administered, patient experienced the following problems/side effects: blood bilirubin abnormal, gilbert's syndrome, liver function test abnormal, no adverse reaction, . LIPITOR dosage: unknown. During the same period patient was treated with ZOCOR. Patient recovered.
BLOOD BILIRUBIN ABNORMAL : Alimta Side Effects Report #5521176-9
Physician from UNITED STATES reported ALIMTA problem on Nov 09, 2007. Male patient was diagnosed with adenocarcinoma pancreas and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: blood albumin abnormal, blood bilirubin abnormal, blood glucose abnormal, chest x-ray abnormal, supraventricular tachycardia, . ALIMTA dosage: 300 MG/M2, OTHER. During the same period patient was treated with LEVAQUIN, COUMADIN, MIRALAX, LOVENOX, LOPRESSOR, SENOKOT, ASPIRIN. Patient was hospitalized. Patient recovered.
BLOOD BILIRUBIN ABNORMAL : Winrho Side Effects Report #5531284-4
WINRHO SDF problem was reported by a Consumer or non-health professional from CANADA on Nov 12, 2007. Male patient, 74 years of age, was diagnosed with idiopathic thrombocytopenic purpura and was treated with WINRHO SDF. After drug was administered, patient experienced the following problems/side effects: bacterial infection, blood bilirubin abnormal, blood disorder, blood lactate dehydrogenase abnormal, chills, haemolysis, hypertension, immune system disorder, oxygen saturation decreased, . WINRHO SDF dosage: unknown. During the same period patient was treated with WINRHO SDF, WINRHO SDF. Patient recovered.
BLOOD BILIRUBIN ABNORMAL : Chantix Side Effects Report #5446632-3
Physician from UNITED STATES reported CHANTIX problem on Aug 28, 2007. Male patient, weighting 203.9 lb, was diagnosed with nicotine dependence, diabetes mellitus and was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: asthenia, blood bilirubin abnormal, blood creatinine increased, blood glucose increased, blood urea increased, diarrhoea, dizziness, headache, hyperhidrosis, . CHANTIX dosage: unknown. During the same period patient was treated with INSULIN. Patient recovered.
BLOOD BILIRUBIN ABNORMAL : Etoposide Side Effects Report #5381456-7
ETOPOSIDE problem was reported by a Consumer or non-health professional from NETHERLANDS on July 03, 2007. Male patient, 59 years of age, weighting 145.5 lb, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: atelectasis, blood bilirubin abnormal, bronchospasm, dyspnoea, hepatic function abnormal, hypokalaemia, hyponatraemia, lung infiltration, . ETOPOSIDE dosage: unknown. During the same period patient was treated with CYTARABINE, DAUNORUBICIN. Patient recovered.
BLOOD BILIRUBIN ABNORMAL : Mirtazapine Side Effects Report #5395625-3
Health Professional from CANADA reported MIRTAZAPINE problem on July 16, 2007. Male patient, 45 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: areflexia, blood bilirubin abnormal, blood creatine phosphokinase increased, intentional overdose, platelet count decreased, suicide attempt, therapeutic agent toxicity, unresponsive to stimuli, vestibular disorder, . MIRTAZAPINE dosage: 225 MG ONCE ORAL. During the same period patient was treated with BACLOFEN, VECURONIUM BROMIDE, SUCCINYLCHOLINE CHLORIDE, PROPOFOL, MIDAZOLAM. Patient was hospitalized. Patient recovered.
BLOOD BILIRUBIN ABNORMAL : Etoposide Side Effects Report #5381456-7
ETOPOSIDE problem was reported by a Consumer or non-health professional from NETHERLANDS on July 03, 2007. Male patient, 59 years of age, weighting 145.5 lb, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: atelectasis, blood bilirubin abnormal, bronchospasm, dyspnoea, hepatic function abnormal, hypokalaemia, hyponatraemia, lung infiltration, . ETOPOSIDE dosage: unknown. During the same period patient was treated with CYTARABINE, DAUNORUBICIN. Patient recovered.
BLOOD BILIRUBIN ABNORMAL : Mirtazapine Side Effects Report #5395625-3
Health Professional from CANADA reported MIRTAZAPINE problem on July 16, 2007. Male patient, 45 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: areflexia, blood bilirubin abnormal, blood creatine phosphokinase increased, intentional overdose, platelet count decreased, suicide attempt, therapeutic agent toxicity, unresponsive to stimuli, vestibular disorder, . MIRTAZAPINE dosage: 225 MG ONCE ORAL. During the same period patient was treated with BACLOFEN, VECURONIUM BROMIDE, SUCCINYLCHOLINE CHLORIDE, PROPOFOL, MIDAZOLAM. Patient was hospitalized. Patient recovered.
BLOOD BILIRUBIN ABNORMAL : Argatroban Side Effects Report #5671888-1
ARGATROBAN problem was reported by a Consumer or non-health professional from JAPAN on Feb 27, 2008. Male patient, 60 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with ARGATROBAN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, blood alkaline phosphatase abnormal, blood bilirubin abnormal, blood lactate dehydrogenase abnormal, gamma-glutamyltransferase abnormal, hepatic function abnormal, . ARGATROBAN dosage: unknown. During the same period patient was treated with AMPHOTERICIN B, ANTIBIOTICS. Patient was hospitalized and became disabled. Patient recovered.
BLOOD BILIRUBIN ABNORMAL : Enbrel Side Effects Report #5640595-3
Consumer or non-health professional from UNITED STATES reported ENBREL problem on Feb 14, 2008. Female patient was diagnosed with psoriatic arthropathy and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase abnormal, aspartate aminotransferase abnormal, blood bilirubin abnormal, liver function test abnormal, . ENBREL dosage: unknown. Patient recovered.
BLOOD BILIRUBIN ABNORMAL : Intralipid Side Effects Report #5603415-9
INTRALIPID problem was reported by a Consumer or non-health professional from on Dec 07, 2007. Male patient, weighting 2.43 lb, was diagnosed with parenteral nutrition and was treated with INTRALIPID. After drug was administered, patient experienced the following problems/side effects: abdominal distension, bilirubin conjugated abnormal, blood bilirubin abnormal, failure to thrive, hepatic enzyme increased, incorrect dose administered, intraventricular haemorrhage, neonatal disorder, . INTRALIPID dosage: unknown. During the same period patient was treated with PARENTERAL NUTRITION. Patient recovered.
BLOOD BILIRUBIN ABNORMAL : Tracleer Side Effects Report #5578545-0
Consumer or non-health professional from GERMANY reported TRACLEER problem on Dec 12, 2007. Female patient, 26 years of age, weighting 114.6 lb, was diagnosed with pulmonary hypertension and was treated with TRACLEER. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin abnormal, infection, pyrexia, . TRACLEER dosage: 125 MG, BID, ORAL. During the same period patient was treated with ENOXAPARIN, ACETYLDIGOXIN, ACETYLSALICYLIC ACID SRT, ZYPREXA, TOREM, PANTOZOL, SPIRONOLACTONE, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.
BLOOD BILIRUBIN ABNORMAL : Bevacizumab Side Effects Report #5483065-8
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 26, 2007. Female patient, weighting 101.4 lb, was diagnosed with colon cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase abnormal, aspartate aminotransferase abnormal, blood bilirubin abnormal, neutrophil count decreased, onycholysis, platelet count decreased, pyrexia, white blood cell count decreased, . BEVACIZUMAB dosage: 5 MG/KG, QD. During the same period patient was treated with ISOVORIN, OXALIPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.
BLOOD BILIRUBIN ABNORMAL : Bevacizumab Side Effects Report #5483068-3
Physician from UNITED KINGDOM reported BEVACIZUMAB problem on Sept 27, 2007. Male patient was diagnosed with colon cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase abnormal, aspartate aminotransferase abnormal, blood bilirubin abnormal, platelet count abnormal, pneumonia aspiration, white blood cell count abnormal, . BEVACIZUMAB dosage: unknown. During the same period patient was treated with OXALIPLATIN, ISOVORIN, FLUOROURACIL. Patient died on 09/26/2007.
BLOOD BILIRUBIN ABNORMAL : Bevacizumab Side Effects Report #5483076-2
BEVACIZUMAB problem was reported by a Physician from UNITED KINGDOM on Sept 26, 2007. Male patient was diagnosed with colon cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase abnormal, aspartate aminotransferase abnormal, blood bilirubin abnormal, hyperbilirubinaemia, metastasis, neuropathy peripheral, palmar-plantar erythrodysaesthesia syndrome, platelet count abnormal, platelet count decreased, . BEVACIZUMAB dosage: 10 MG/KG, UNK. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN, LOXONIN, URSO, MUCOSTA, FAMOTIDINE. Patient recovered.